目前的趋势和可用的证据,低水平的激光治疗骨质放射性缩:一个范围审查
Larissa Di Carvalho Melo1, Bruna Bastos Silveira1, Mylene Martins Monteiro1
1University of Brasilia, Laboratory of Oral Histopathology, School of Health Sciences Faculty, Brasília Brazil.
Photodiagnosis and photodynamic therapy
|October 19, 2024
概括
低水平激光疗法 (LLLT) 在治疗和预防骨质放射性瘤方面表现有前途. 然而,当前研究中的不一致的激光参数阻碍了标准化方案,需要进一步研究临床整合.
科学领域:
- 生物医学工程 生物医学工程
- 口腔和牙面部外科手术
- 在瘤学瘤学.
背景情况:
- 骨质放射性死 (ORN) 是放射治疗后的一种严重并发症.
- 低水平激光疗法 (LLLT) 正在探索其在管理ORN的治疗和预防潜力.
研究的目的:
- 对ORN治疗和预防中LLLT的当前趋势和证据进行范围审查.
- 确定现有研究中使用的共同LLLT协议和参数.
主要方法:
- 在主要数据库 (MEDLINE/PubMed,EMBASE,Web of Science) 和灰色文献中进行了全面的文献搜索.
- 在2024年1月15日进行的搜索中,没有语言或时间限制.
- 十九项研究符合审查的纳入标准.
主要成果:
- 在ORN管理中,LLLT用于治疗 (58%),预防 (21%),和联合 (21%) 的用途.
- 在41%的研究中使用了抗微生物光动力疗法 (aPDT),通常使用甲蓝.
- 在近红外 (780-904 nm) 和红 (660 nm) 波长的二极管激光器是常用的,主要是在连续发射模式.
结论:
- 在ORN中,LLLT展示了治疗和预防应用的潜力.
- 在研究中报告的激光参数的显著变化使标准化协议的建立变得复杂.
- 专注于协议标准化的进一步精心设计的临床试验对于ORN的LLLT可靠的临床整合至关重要.
相关概念视频
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


